Kirsten, M.F., Dykeman, J., Patten, S.B., Wiebe, S., Kaplan, G.G., Maxwell, C.J., Bulloch, A.G.M. and Jette, N. (2013) Depression in Epilepsy: A Systematic Review and Meta-Analysis. Neurology, 80, 590-599.
https://doi.org/10.1212/WNL.0b013e31827b1ae0

has been cited by the following article:

• TITLE: The Antidepressant Mechanism of JiaWeiWenDan Decoction Regulating p38MAPK-ERK5 Signal Transduction Pathway

  AUTHORS: Yue Gao, Qi Zhang, Li Wu, Jianye Dai

  KEYWORDS: JiaWeiWenDan Decoction, Depression, p38MAPK-ERK5 Signal Transduction Pathway

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.4, April 23, 2023

  ABSTRACT: Objective: To investigate the anti-depression mechanism of JiaWeiWenDan Decoction in regulating p38MAPK-ERK5 signal transduction pathway. Methods: Depression model rats were randomly divided into Blank Control Group, Model Control Group, Chinese Medicine Treatment Group, and Western Medicine Treatment Group (hereinafter referred to as Blank Group, Model Group, Chinese Medicine Group, and Western Medicine Group), with 48 rats in each group. The mice were treated with p38MAPK-ERK5 on the 7th day, 14th day and 21st day, respectively, and the mice were treated for 28 days. The key targets and cytokines in p38MAPK-ERK5 signal transduction pathway were detected. Results: Compared with the Blank Group, the expression of p38MAPKmRNA in the hippocampus of the Model Group was increased. The Chinese Medicine Group and Western Medicine Group could reduce the expression of p38MAPK mRNA (P P P P Conclusion: The anti-inflammatory effect of JiaWeiWenDan Decoction may be related to the regulation of p38MAPK-ERK5 signaling pathway. With the advance of the treatment week, the best effect was obtained when the treatment was started on the 7th day of modeling.